“Venom: The Last Dance” hopes to sink its teeth into at least $65 million in its box office debut. The third and final entry in the Tom Hardy-led antihero franchise is landing in 4,125 North American theaters on Friday.
Those ticket sales would be far behind the prior two installments, 2018’s “Venom” (which opened to $80 million) and 2021’s “Venom: Let There Be Carnage” (which opened to $90 million, setting a then pandemic-era record). The comic book installment looking to get a lift from international audiences; “Venom 3” is projected to add $85 million overseas for a global start of $150 million.
“The Last Dance” cost $120 million to produce, not including worldwide marketing efforts. Since theater owners get to keep roughly half of ticket sales, “Venom 3” needs to stick around on the big screen beyond its debut to justify that price tag. Kelly Marcel, who wrote the first two films, directed the PG-13 threequel, which stars…
Please wait while you are redirected...or Click Here if you do not want to wait.
